Clinical characteristics and outcomes of the oldest old people with type 2 diabetes - perspective from a tertiary diabetes center in Thailand

被引:11
|
作者
Yotsapon, Thewjitcharoen [1 ]
Sirinate, Krittiyawong [1 ]
Ekgaluck, Wanothayaroj [1 ]
Somboon, Vongterapak [1 ]
Tawee, Anuntakulnatee [1 ]
Worawit, Kittipoom [1 ]
Soontaree, Nakasatien [1 ]
Thep, Himathongkam [1 ]
机构
[1] Theptarin Hosp, Diabet & Thyroid Ctr, Bangkok, Thailand
来源
BMC ENDOCRINE DISORDERS | 2016年 / 16卷
关键词
Oldest old; Type; 2; diabetes; Thailand; Deintensification; GLYCEMIC CONTROL; LACTIC-ACIDOSIS; MELLITUS; METAANALYSIS; ASSOCIATION; ADULTS; RATES; GOALS; RISK;
D O I
10.1186/s12902-016-0115-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Advance in medicine has led to an increase in life expectancy of elderly diabetic patients especially on the growing population called the "oldest old", those in their mid-80s upwards. The aim of this study is to describe clinical characteristics and outcomes of "oldest old" patients in a specialized diabetes center. Methods: A retrospective review was conducted on medical records of type 2 diabetes who were older than 85 years at Theptarin hospital from September 2014 to August 2015. Results: During the study period, there were 143 oldest old diabetic patients who visited our hospital regularly. Of the 133 active follow-up patients (median time of follow-up 15 years, range 1-30 years), 70.7 % was female, the mean age of onset was 68.3 +/- 11.5 years and duration of diabetes was 20.1 +/- 11.1 years. According to the Charlson co-morbidity index (CCI), 35.3 % of patients were classified as having severe co-morbidities. The mean A1C, blood pressure, LDL were 6.7 +/- 1.1 %, 132/65 mmHg and 80 +/- 29 mg/dl respectively. 66.9 % of patients had tight glycemic control (A1C <7 %) while 12.0 % had poor control (A1C >8 %). Oral hypoglycemic agent (OHA) dual therapy was the most common treatment (26.3 %) followed by OHA monotherapy (22.6 %), insulin alone (19.5 %), diet therapy alone (12.7 %), and insulin plus OHA (8.3 %). Hypoglycemia was found in 10.5 % of patients in previous 12 months. Diabetic retinopathy, chronic kidney disease, cardiovascular disease, and stroke were presented in 23.4, 54.9, 15.8, 18.0 % of patients, respectively. Among patients whose received diabetic medications and resulted in very low level of A1C (A1C less than 6.0 %), only 20.0 % underwent deintensification. Conclusions: Our results revealed that real-world clinical outcomes of extreme elderly diabetic patients were diverse and being too "aggressive" diabetes treatment with older patients did occur frequently. Decision making in older people with diabetes is complex as chronic co-morbidities are very common.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10
    Hutchins, Jessica
    Barajas, Rose Ann
    Hale, Daniel
    Escaname, Elia
    Lynch, Jane
    PEDIATRIC DIABETES, 2017, 18 (07) : 674 - 677
  • [42] Impact of diabetes self-management, diabetes management self-efficacy and diabetes knowledge on glycemic control in people with Type 2 Diabetes (T2D): A multi-center study in Thailand
    Hurst, Cameron P.
    Rakkapao, Nitchamon
    Hay, Karen
    PLOS ONE, 2020, 15 (12):
  • [43] Treatment and Outcomes of Type 2 Diabetes Patients Referred to an Outpatients Diabetes Clinic of a Tertiary Teaching Hospital
    Omer, Safaa H.
    Abdulla, Mohy E. Y.
    Awwad, Mohammad A.
    El-Gied, Amgad A. A.
    Alolayan, Sultan O.
    Alahmadi, Yaser
    Mahmoud, Mansour A.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (04): : 755 - 761
  • [44] Colesevelam, Ezetimibe, and Patients With Type 2 Diabetes Mellitus: Characteristics and Clinical Outcomes From a Health Care Database
    Swindle, Jason P.
    Ye, Xin
    Mallick, Rajiv
    Song, Rui
    Horstman, Thomas
    Bays, Harold E.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (07) : 847 - 855
  • [45] International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS
    Bhatt, Ankeet S.
    Luo, Nancy
    Solomon, Nicole
    Pagidipati, Neha J.
    Ambrosio, Giuseppe
    Green, Jennifer B.
    McGuire, Darren K.
    Standl, Eberhard
    Cornel, Jan H.
    Halvorsen, Sigrun
    Lopes, Renato D.
    White, Harvey D.
    Holman, Rury R.
    Peterson, Eric D.
    Mentz, Robert J.
    AMERICAN HEART JOURNAL, 2019, 218 : 57 - 65
  • [46] THE PATIENT PERSPECTIVE ON ACHIEVING NEAR NORMOGLYCEMIA IN PEOPLE WITH TYPE 2 DIABETES
    Gelhorn, H.
    Ross, M.
    Shinde, S.
    Thieu, V. T.
    Boye, K.
    VALUE IN HEALTH, 2022, 25 (01) : S242 - S242
  • [47] Characterisation of Type 2 Diabetes mellitus in children and young people across 2 large tertiary Paediatric Diabetes centres
    Chatterjee, Sumana
    Baioumi, Alaa
    Pryce, Rebekah
    Williams, Georgina
    Giri, Dinesh
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 169 - 169
  • [48] Child Opportunity Index and clinical characteristics at diabetes diagnosis in youth: type 1 diabetes versus type 2 diabetes
    Hoyek, Kim
    Libman, Ingrid
    Mkparu, Nkeiruka
    Hong, Yong Hee
    Arslanian, Silva
    Vajravelu, Mary Ellen
    BMJ OPEN DIABETES RESEARCH & CARE, 2024, 12 (02)
  • [49] Clinical Outcomes with V-Go in Type 2 Diabetes Based on Duration of Diabetes
    Cases, Jane
    Kowalyk, Stephan
    Hundal, Ripu S.
    Al-Karadsheh, Amer
    Wakim, Amanda P.
    Doyle, Melissa
    Sink, John H., II
    Spence, Adrienne
    Brewer, Jamie L.
    Nikkel, Carla C.
    DIABETES, 2018, 67
  • [50] A Clinical Perspective of Canagliflozin in the Management of Type 2 Diabetes Mellitus
    Nardolillo, Annemarie
    Kane, Michael P.
    Busch, Robert S.
    Watskyand, Jay
    Hamilton, Robert A.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2014, 7 : 25 - 30